AIP
MIRM icon

Ameritas Investment Partners’s Mirum Pharmaceuticals MIRM Stock Holding History

Ameritas Investment Partners’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$505K Buy
4,310
+827
+24% +$83K 0.01% 907
2026
Q1 		$322K Buy
3,483
+111
+3% +$10.4K 0.01% 1006
2025
Q4 		$266K Hold
3,372
– – 0.01% 1090
2025
Q3 		$247K Sell
3,372
-1,067
-24% -$67.8K 0.01% 1114
2025
Q2 		$226K Buy
4,439
+284
+7% +$12.6K 0.01% 1226
2025
Q1 		$187K Hold
4,155
– – 0.01% 1300
2024
Q4 		$172K Buy
4,155
+312
+8% +$13K 0.01% 1417
2024
Q3 		$150K Hold
3,843
– – ﹤0.01% 1526
2024
Q2 		$131K Buy
3,843
+1,206
+46% +$31.6K ﹤0.01% 1555
2024
Q1 		$66.2K Hold
2,637
– – ﹤0.01% 1990
2023
Q4 		$77.8K Hold
2,637
– – ﹤0.01% 1902
2023
Q3 		$83.3K Buy
2,637
+429
+19% +$11.7K ﹤0.01% 1779
2023
Q2 		$57.1K Buy
2,208
+1,016
+85% +$27K ﹤0.01% 1967
2023
Q1 		$28.6K Hold
1,192
– – ﹤0.01% 2305
2022
Q4 		$25.6K Hold
1,192
– – ﹤0.01% 2453
2022
Q3 		$25K Hold
1,192
– – ﹤0.01% 2410
2022
Q2 		$23K Buy
1,192
+967
+430% +$22.8K ﹤0.01% 2486
2022
Q1 		$5K Hold
225
– – ﹤0.01% 2971
2021
Q4 		$4K Hold
225
– – ﹤0.01% 3061
2021
Q3 		$4K Hold
225
– – ﹤0.01% 3048
2021
Q2 		$4K Hold
225
– – ﹤0.01% 3009
2021
Q1 		$4K Hold
225
– – ﹤0.01% 3030
2020
Q4 		$4K Hold
225
– – ﹤0.01% 3002
2020
Q3 		$4K Hold
225
– – ﹤0.01% 3011
2020
Q2 		$4K Hold
225
– – ﹤0.01% 2996
2020
Q1 		$3K Hold
225
– – ﹤0.01% 2919
2019
Q4 		$6K Hold
225
– – ﹤0.01% 2880
2019
Q3 		$2K Buy
+225
New +$2.76K ﹤0.01% 3024

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ameritas Investment Partners's MIRM Position: Q2 2026 in Review

Ameritas Investment Partners increased its Mirum Pharmaceuticals (MIRM) stake by 24% in Q2 2026, buying an estimated $83K and bringing the position to 4,310 shares worth $505K. The position accounts for 0.01% of the portfolio, ranked #907.

Ameritas Investment Partners first reported a position in MIRM in Q3 2019 and has held it in 28 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Ameritas Investment Partners held 4,310 shares of Mirum Pharmaceuticals worth $505K as of Q2 2026.
  • Ameritas Investment Partners bought 827 Mirum Pharmaceuticals shares in Q2 2026, an estimated $83K.
  • Mirum Pharmaceuticals made up 0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #907 holding.
  • Ameritas Investment Partners first reported a position in Mirum Pharmaceuticals in Q3 2019 and has held it in 28 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.